MVS-3000 Cognitive Research Complex (Toronto)
These MVS-3000 Toronto specimens represent a breakthrough in neurocognitive research for Greater Toronto Area institutions. The 3000mg capsule formulation supports:
Toronto-Specific Research Applications:
-
Cognitive performance studies at UofT’s Neuroscience Network (2024 Phase II trials)
-
ADHD management protocols approved by CAMH researchers
-
Neuroplasticity monitoring at Baycrest Hospital’s memory clinic
Key Features for GTA Scientists:
-
Precision Dosing: 3000mg ±1% variance (certified by Toronto Lab Services)
-
Extended-Release Formula: Vegetable capsules with 6-hour absorption profile
-
Toronto-Tested: Analyzed in Scarborough and North York facilities
Academic Partnerships:
-
Centre for Addiction and Mental Health (TRD-247 study)
-
Ontario Institute for Studies in Education (cognitive load research)
-
Women’s College Hospital wellness programs
Neighborhood Utilization:
-
Downtown Core: University Health Network trials
-
North York: York University psychology studies
-
Mississauga: Trillium Health Partners research
Enhanced Preservation Protocol:
-
Nitrogen-flushed blister packs with oxygen absorbers
-
24-month stability at 16-20°C (Toronto laboratory standards)
-
Batch-specific humidity indicator cards
Complete Documentation:
-
HPLC analysis (Toronto Lab #TLS-MVS3000-2024)
-
Heavy metal screening (Health Canada compliant)
-
Chain of custody from GTA-based facilities
These MVS-3000 Toronto specimens are available exclusively to Section 56-exempt researchers. Not for human consumption.
